Back
Exelixis Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Buy
84
EXEL
Exelixis
Last Price:
35.62
Seasonality Move:
13.23%
Sell
48
CPRX
Catalyst Pharmaceuticals
Last Price:
21.47
Seasonality Move:
4.48%
Buy
84
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $35.61. The Score for EXEL is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
48
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $21.48. The Score for CPRX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.48
The current trend is relatively stagnant and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.59 | Buy |
| Relative Strength Index (14 RSI): | 72.44 | Buy |
| Chaikin Money Flow: | 1478964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.05 - 36.05) | Buy |
| Bollinger Bands (100): | (23.18 - 31.22) | Buy |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 48.92 | Sell |
| Chaikin Money Flow: | 621365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.03 - 22.71) | Sell |
| Bollinger Bands (100): | (17.61 - 21.71) | Buy |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.84 | Buy |
| 20-day SMA: | 34.22 | Buy |
| 50-day SMA: | 29.85 | Buy |
| 200-day SMA: | 24.68 | Buy |
| 8-day EMA: | 34.93 | Buy |
| 20-day EMA: | 33.75 | Buy |
| 50-day EMA: | 30.88 | Buy |
| 200-day EMA: | 25.85 | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.38 | Buy |
| 20-day SMA: | 22 | Sell |
| 50-day SMA: | 21.11 | Buy |
| 200-day SMA: | 17.57 | Buy |
| 8-day EMA: | 21.5 | Sell |
| 20-day EMA: | 21.67 | Sell |
| 50-day EMA: | 21.07 | Buy |
| 200-day EMA: | 18.25 | Buy |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.01 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
Exelixis Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||